相关实验视频

Updated: May 12, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

T细胞衰老:为周期性免疫调节的重要目标

Haoning Lan¹, Songchao Xu¹, Huili Li¹

¹Department of Anaesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, 100050, People's Republic of China.

Clinical interventions in aging

|May 7, 2025

概括

术后并发症会影响T细胞衰老,影响患者的康复. 识别高风险个体和采用预康复等干预措施可以改善结果.

科学领域:

免疫学免疫学免疫学
老年学是一门学科.
麻醉学麻醉学

背景情况:

T细胞对免疫功能至关重要,但它们的作用和衰老过程随着年龄的增长而发生显著变化.
外科手术期间的疼痛和压力可能会损害免疫状态,影响患者的康复.
T细胞衰老是一个独特的过程,具有临床指标,受到各种健康因素的影响.

研究的目的:

检查手术前和手术后并发症如何影响T细胞衰老.
确定患有术后T细胞衰老高风险的患者群体.
讨论T细胞衰老对术后结果和潜在干预措施的影响.

主要方法:

对有关T细胞衰老的现有文献进行审查和分析.
确定影响T细胞衰老的各种手术前和手术内因素.
讨论临床指标和潜在的治疗策略.

主要成果:

许多因素,包括慢性疾病 (高血压,糖尿病),急性疾病 (ARDS,低氧症),心理状态 (抑郁症),疼痛,肥胖,神经和自身免疫疾病,麻醉选择,手术类型和药物,都会影响T细胞衰老.
患有多种并发症的老年癌症患者被确定为外科手术期间T细胞衰老的高风险组.
T细胞衰老与术后神经功能障碍和恢复质量的降低有关.

结论:

手术前和手术后的并发症显著影响T细胞衰老.
针对性干预,如预康复,药物治疗和采用性神经免疫疗法,在调节T细胞衰老方面表现有前途.
在外科手术期间调节T细胞衰老可能会改善临床预后并改善患者的康复.

关键词:

CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 CD57 在T细胞衰老过程中.免疫调节免疫调节免疫调节在外科手术期间.与衰老相关的分泌表现型终端效应器记忆T细胞T细胞

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

相关概念视频

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...